▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Tenaya Therapeutics (NASDAQ: TNYA)

$0.67

(-0.5%)

-$0.00

Price as of August 1, 2025, 3:58 p.m. ET

Tenaya Therapeutics Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
TNYA	-78.95%			-96%
S&P	+14.53%	+90.70%	+13.76%	+42%

Tenaya Therapeutics Company Info

Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in August 2016 and is headquartered in South San Francisco, CA.

News & Analysis

Featured Article

Why This Nasdaq Stock Caught Fire This Week

A wave of bargain buying benefited the gene therapy company's shares this week.

George Budwell | Apr 20, 2023

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services